GE Medical Systems of Milwaukee has received Food and Drug Administrationclearance for two new mammography systems, Senographe 700-T andSenographe 800-T. The systems were introduced at last year's RadiologicalSociety of North America meeting and are
GE Medical Systems of Milwaukee has received Food and Drug Administration
clearance for two new mammography systems, Senographe 700-T and
Senographe 800-T. The systems were introduced at last year's Radiological
Society of North America meeting and are designed to occupy price
points below that of the premium Senographe DMR (SCAN 12/27/95).
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.